Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Intramyocardial Injection of Autologous Bone Marrow Derived Mononuclear Stem Cells in Heart Failure (HF) Patients

NCT03227198 is registered in ClinicalTrials.gov with SCARM Institute, Tabriz, Iran as lead sponsor.

NCT NCT03227198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03227198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Intramyocardial Injection of Autologous Bone Marrow Derived Mononuclear Stem Cells in Heart Failure (HF) Patients
Lead sponsor
SCARM Institute, Tabriz, Iran
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 14, 2020
Completion date
October 12, 2021
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure